John J. Baldwin - Co-Founder @ iVIEW Therapeutics

Start Free Trial

Pricing

Overview

Number of Founded Organizations

CB Rank (Person)

238,427

Primary Job Title Co-Founder
Primary Organization
iVIEW Therapeutics

Location Shanghai, Shanghai, China
Regions Asia-Pacific (APAC)
Gender Male

LinkedIn View on LinkedIn

John Baldwin is the Co-Founder of iVIEW Therapeutics. John previously worked at Vitae Pharmaceuticals as a President. He attended the Univ. of Delaware and Univ. of Minnesota.

Jobs

Number of Current Jobs

Number of Past Jobs

John J. Baldwin

has

current jobs as

Co-Founder

iVIEW Therapeutics

and

Director

GlycoMimetics

. Additionally,

John J. Baldwin

has had

past jobs including

Co-Founder and Chief Scientific and Technology Officer

Pharmacopeia

iVIEW Therapeutics Co-Founder
GlycoMimetics Director

Organization Name	Title At Company	Start Date	End Date
Pharmacopeia	Co-Founder and Chief Scientific and Technology Officer	—	—
Merck	Senior Scientist	—	—
Vitae Pharmaceuticals	President and Chief Scientific Officer	—	—
WuXi AppTec	Board of Directors, Co-Founder	—	—
Vitae Pharmaceuticals	Co-Founder	—	—

Related Hubs

Hub Name	CB Rank (Hub)
Medical Early Stage Companies With Fewer Than 50 Employees	35,707
Therapeutics Early Stage Companies With Fewer Than 100 Employees	51,329
Cowin Capital Portfolio Companies	54,513
Medical Early Stage Companies With More Than 10 Employees	34,061
Medical Device Startups	15,144
Therapeutics Early Stage Companies With Fewer Than 50 Employees	52,389
Medical Device Early Stage Companies With More Than 10 Employees	37,634
Medical Device Early Stage Companies With Fewer Than 1000 Employees	33,324
Therapeutics Companies with Early Stage Venture Funding	46,003
Therapeutics Early Stage Companies With More Than 10 Employees	58,154

Education

John J. Baldwin

studied at

University of Minnesota

and

Delaware State University

University of Minnesota PhDOrganic Chemistry19521960
Delaware State University BSChemistry19521960

Recent News and Activity

There is no recent news or activity for this profile.